Arca
Skip to content
Tools
Tools

Common cold

Drug research and approvals for common cold: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 18, 2026, 12 studies of common cold are recruiting on ClinicalTrials.gov, and Health Canada has authorized 1 drug trials for it since 2013.

  • Recruiting worldwide: 12
  • Trials authorized in Canada: 1
  • FDA orphan approvals: 0
  • EU medicines: 0

Recruiting now

Newest start dates first, of 12 recruiting on ClinicalTrials.gov ↗

Drug pipeline

18 approved, 10 in phase 3, 6 in phase 2, 1 in phase 1 or earlier; from ChEMBL's drug indications, furthest stage reached for this condition

Approved: Acetaminophen, Phenylephrine, Ibuprofen, Aspirin, Dextromethorphan, Pseudoephedrine, Menthol, Naphazoline, Oxymetazoline, Naproxen, Ephedrine, Ipratropium, Chlorpheniramine, Brompheniramine, Clemastine, Triprolidine, Diphenhydramine, Camphor

Acetylcysteine
Phase 3 Glutathione precursor
Lidocaine
Phase 3 Sodium channel alpha subunit blocker
Azelastine
Phase 3 Histamine H1 receptor antagonist
Desloratadine
Phase 3 Histamine H1 receptor antagonist
Pheniramine
Phase 3 Histamine H1 receptor antagonist
Capsaicin
Phase 3 Vanilloid receptor opener
Caffeine
Phase 3 Adenosine receptor antagonist
Xylometazoline
Phase 3 Adrenergic receptor alpha agonist
Panthenol
Phase 3
Cholecalciferol
Phase 2 Vitamin D receptor agonist
Guaifenesin
Phase 2 Unknown
Dextrose
Phase 2
Glucagon
Phase 1 Glucagon receptor agonist

How its trials ended

157 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrong

Of the 41 whose ending is known, 44% met their primary endpoint, 15% missed it and 41% stopped early.

  • Completed, result not reported9259%
  • Met its primary endpoint1811%
  • Ongoing149%
  • Stopped: other or unclear138%
  • Status unknown106%
  • Missed its primary endpoint64%
  • Stopped: enrollment or feasibility32%
  • Stopped: lack of efficacy11%

Trials authorized in Canada

Newest first; search them all in Canada trials
AuthorizedTrialSponsorStatus
Jul 27, 2017Randomized, double-blind, placebo-controlled, study of the efficacy of phenylephrine hcl extended-release 30 mg and phenylephrine hcl immediate-release 12 mg…PhenylephrineJohnson & Johnson ConsumerOngoing

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.